Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival
Key Points
Key points are not available for this paper at this time.
Abstract
Continuing five or more locoregional therapies for recurrent HCC after LR is related to poor recurrence-free survival after SLT.
KI fragen
Like
Bookmark
Share
View Full Paper
KI fragen
Like
Bookmark
Share
View Full Paper
Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival | Synapse